Clinical Chemistry

27 March 2019

Suntec Singapore

Key topics:

  • Advances in mass spectrometry
  • Unusual thyroid function tests
  • Old and new biomarkers for kidney disease
  • Stroke biomarkers discovery
  • Parathyroid Hormone Measurement

Benefits of attending:

  • Identify latest updates in assays
  • Appraise use of biomarkers in clinical laboratory
  • Review diagnostic and prognostic biomarkers for kidney
  • Discuss glycation markers in diabetes

09:50

Opening remarks

Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore


Session 1

10:00

More unusual thyroid function tests

A/Prof Chris Florkowski, Associate Professor, Canterbury Health Laboratories, Christchurch, New Zealand


10:30

Parathyroid Hormone Measurement in Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)

Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore


11:00

The role of bone markers in investigation and management of metabolic bone disease

Dr Samuel Vasikaran, Consultant Chemical Pathologist, PathWest - Fiona Stanley and Royal Perth Hospitals, Perth, Australia


11:30

Q&A


11:45

Lunch break and visit exhibition


Session 2

13:00

Clinical case interpretation

Dr Wong Moh Sim, Head & Sr Consultant, Dept of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore


13:30

The role of moving patient means in quality assurance

Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia -  Quality Assurance Programs (RCPAQAP), New South Wales, Australia


14:00

Glycation markers in diabetes

Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Gent, Belgium


14:30

Q&A


14:45

Coffee Break


Session 3

15:15

Implementing mass spectrometry in the clinical laboratory

Jayme Wong, Senior Principal Medical Laboratory Scientist, Department of Clinical Pathology, Singapore General Hospital, Singapore


15:45

Measurement uncertainty

Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia -  Quality Assurance Programs (RCPAQAP), New South Wales, Australia


16:15

New biomarkers for management of acute heart failure

Prof Salvatore Di Somma, President, GREAT Network; Professor of Medicine, Chairman and Director Emergency Medicine, Sapienza University of Rome, Rome, Italy


16:45

Q&A


17:00

End of conference

Conference Chairs:

Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore

A/Prof Chris Florkowski, Associate Professor, Canterbury Health Laboratories, Christchurch, New Zealand


Speaker Faculty:

Jayme Wong, Senior Principal Medical Laboratory Scientist, Department of Clinical Pathology, Singapore General Hospital, Singapore

Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Gent, Belgium

Prof Salvatore Di Somma, President, GREAT Network; Professor of Medicine, Chairman and Director Emergency Medicine, Sapienza University of Rome, Rome, Italy

Dr Samuel Vasikaran, Consultant Chemical Pathologist, PathWest - Fiona Stanley and Royal Perth Hospitals, Perth, Australia

Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia -  Quality Assurance Programs (RCPAQAP), New South Wales, Australia

Dr Wong Moh Sim, Head & Sr Consultant, Dept of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore